【US Stock Market Odd Move】Oruka Therapeutics sharply dropped on September 23: insider selling, major shareholder dumping, and high-level correction

Oruka Therapeutics September 23 Major Drop Analysis

Keywords: Insider selling, major shareholder offloading, pullback from highs

1. On September 21, 2026, the company's General Counsel sold 10 thousand shares, cashing out 936,400 USD; On September 23, reports stated that Fairmount sold approximately 3.55 million shares, increasing the stock supply.

2. On September 23, 2026, the company announced positive 28-week data for ORKA-001, but the full 52-week data for EVERLAST-A is expected to be released in December, and the 16-week data for EVERLAST-B is expected to be released in the fourth quarter. Long-term efficacy and dosing schedule still need to be verified.

3. In the three months leading up to August 28, 2026, the stock price rose about 65% cumulatively, and year-to-date increased by about 189.59%. Short-term capital took profits after the clinical data was released.

(Disclaimer: This content is generated by AI technology based on publicly available information and is for reference only. It does not constitute investment advice.)